These frequencies suggest that universal MMR deficiency testing of all Lynch-spectrum tumours would have an equivalent sensitivity for LS detection as MMR deficiency testing of CRCs and ECs. This evidence concerns the gene MRC1 and mismatch repair cancer syndrome 1.